|
The number of mice with viable S. Typhimurium and granulomas in liver and spleen |
|||||
| Experimental groups |
Number (%) of mice with |
||||
|
|
|||||
| Salmonella Typhimurium |
Granulomas |
||||
|
|
|||||
| ileum |
blood |
liver |
liver |
spleen |
|
|
|
|||||
| Gr1 (ST) |
111;2 |
3 |
113 |
164;5 |
117 |
| n = 20 |
55% |
15% |
55% |
80% |
55% |
|
|
|||||
| Gr2 (ST+OFX) |
21 |
1 |
3 |
86 |
07;8 |
| n = 13 |
15% |
8% |
23% |
62% |
|
|
|
|||||
| Gr3 (ST+ME-3) |
21 |
0 |
13 |
54 |
48 |
| n = 13 |
15% |
8% |
38% |
31% |
|
|
|
|||||
| Gr4 (ST+OFX+ME-3) |
02 |
0 |
0 |
25;6 |
07;8 |
| n = 13 |
15% |
||||
|
ST – Salmonella Typhimurium OFX – ofloxacin ME-3 – Lactobacillus fermentum ME-3 1 p = 0.032 Gr1 vs Gr2 and Gr3 viable ST in ileum 2 p = 0.002 Gr1 vs Gr4 viable ST in ileum 3 p = 0.009 Gr1 vs Gr3 viable ST in liver 4 p = 0.027 Gr1 vs Gr3 liver granulomas 5 p < 0.001 Gr1 vs Gr4 liver granulomas 6 p = 0.023 Gr2 vs Gr4 liver granulomas 7 p = 0.002 Gr1 vs Gr2 and Gr4 spleen granulomas 8 p = 0.048 Gr2 vs Gr3 and Gr4 vs Gr3 spleen granulomas | |||||
Truusalu et al. BMC Microbiology 2008 8:132 doi:10.1186/1471-2180-8-132 |
|||||